Trial intelligence / Profile preview

Protein Kinetics in Chronic Intestinal Failure

NCT07422792Recruiting

Sponsor
Institute of Oncology Ljubljana
Start
Apr 2022
Primary completion
Mar 2024
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of compound amino acids injection (18aa-vii) in intestinal failure (IF), sponsored by Institute of Oncology Ljubljana. Primary endpoint: Whole-Body Protein Kinetics (Protein Synthesis Rate). Started Apr 2022; status: recruiting.

02

Drugs

compound amino acids injection (18aa-vii)
03

Conditions

intestinal failure (IF)

Beyond the preview

Go deeper on NCT07422792.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07422792.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call